Results 271 to 278 of about 1,444,670 (278)

In vitro and in vivo preclinical pharmacokinetic characterization of aficamten, a small molecule cardiac myosin inhibitor

Xenobiotica
Jeanelle Zamora, Luke Ashcraft
exaly  

The Efficacy and Safety of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials

American Journal of Cardiology
Andrew M Goldsweig, Chidubem Ezenna, Meghna Joseph   +2 more
exaly  

Combination therapy of cardiac myosin activator and sinus node if current inhibitor

2016
SCOTT ROBERT ANDREW DONALD, WASSERMAN SCOTT   +1 more
openaire   +3 more sources

Current and Future Management of Hypertrophic Cardiomyopathy with Cardiac Myosin Inhibitors

Cardiology Research and Cardiovascular Medicine
openaire   +1 more source

Mavacamten, a first-in-class cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy

Qingwei Zhang, Mengfei Wang, Qiushi Chen
exaly  

Current Evidence in Cardiac Myosin Inhibitors and Future Directions in Medical Therapy

Milind Y. Desai, Iacopo Olivotto, Ahmad Masri   +2 more
openaire   +1 more source

Cardiac myosin inhibitors and risk of atrial fibrillation in hypertrophic cardiomyopathy

openaire   +1 more source

Cardiac Myosin Inhibitors: Is the Emperor Wearing Any Clothes, or Is it Placebo?

Journal of the American College of Cardiology
Rasmussen, Torsten B., Dybro, Anne M., Jensen, Morten Kvistholm   +2 more
openaire   +2 more sources